This study is in progress, not accepting new patients
A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome
Summary
- Eligibility
- for people ages 2 years and up (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Shaun Hussain
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Shaun Hussain
Hs Clinical Professor, Pediatrics, Medicine. Authored (or co-authored) 43 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Zogenix, Inc.
- ID
- NCT03936777
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- About 412 people participating
- Last Updated